Simplifying Global Compliance
FDA Targets ‘Disease Areas’ for Patient-Centered Research Push
Washington Drug Letter
Acting on a mandate of the most recent user fee framework, the FDA has selected more than a dozen disease areas it plans to address as part of a new initiative on patient-centered research through 2015.
To View This Article:
Buy This Article Now
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing